Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potential of TAC-101 in human testicular cancer

March 18, 2003

Aventis scientists prepare and test new tubulin polymerization inhibitors

March 18, 2003

Three related series of antitumor tyrosine kinase inhibitors patented by Merck

March 18, 2003

Results from European phase III trial of Plenaxis discussed at EAU meeting

March 17, 2003

Maxim receives NCI SBIR grant for MX-2167

March 17, 2003

NCI grant for trial of NCX-4016 in prevention of colon cancer

March 17, 2003

Novel HDAC inhibitors in Roche development pipeline

March 17, 2003

Bryostatin-1 increases survival in advanced renal cell carcinoma

March 17, 2003

New antiinflammatory IKK-2 inhibitors in early development at AstraZeneca

March 17, 2003

Teva invests in Gamida-Cell

March 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...